These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1730150)

  • 21. Biomonitoring of aromatic amines V: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by haemoglobin binding.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1998; 72(8):499-504. PubMed ID: 9765065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemoglobin binding in control of exposure to and risk assessment of aromatic amines.
    Neumann HG
    IARC Sci Publ; 1988; (89):157-65. PubMed ID: 3198198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in vivo binding of aromatic nitro and amino compounds to rat hemoglobin.
    Suzuki J; Meguro S; Morita O; Hirayama S; Suzuki S
    Biochem Pharmacol; 1989 Oct; 38(20):3511-9. PubMed ID: 2818643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations of nitrenium ion selectivities with quantitative mutagenicity and carcinogenicity of the corresponding amines.
    Novak M; Rajagopal S
    Chem Res Toxicol; 2002 Dec; 15(12):1495-503. PubMed ID: 12482231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
    Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
    Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of drugs: quantitative structure-activity relationships for barbiturates, tertiary amines, and substituted imidazoles.
    Tong GL; Lien EJ
    J Pharm Sci; 1976 Nov; 65(11):1651-4. PubMed ID: 11333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment.
    Neumann HG; Birner G; Kowallik P; Schütze D; Zwirner-Baier I
    Environ Health Perspect; 1993 Mar; 99():65-9. PubMed ID: 8319661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans.
    Richter E; Branner B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Oct; 778(1-2):49-62. PubMed ID: 12376116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts.
    Albrecht W; Neumann HG
    Arch Toxicol; 1985 Apr; 57(1):1-5. PubMed ID: 4015392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of haemoglobin adducts of aromatic amines by gas chromatography-mass spectrometry.
    Bryant MS; Skipper PL; Wishnok JS; Stillwell WG; Glogowski JA; Tannenbaum SR
    IARC Sci Publ; 1993; (109):281-92. PubMed ID: 8514359
    [No Abstract]   [Full Text] [Related]  

  • 31. Isotope effects and structure-reactivity correlations in the yeast alcohol dehydrogenase reaction. A study of the enzyme-catalyzed oxidation of aromatic alcohols.
    Klinman JP
    Biochemistry; 1976 May; 15(9):2018-26. PubMed ID: 773429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relevance of chemico-biological interactions for the toxic and carcinogenic effects of aromatic amines. V. The pharmacokinetics of related aromatic amines in blood.
    Groth U; Neumann HG
    Chem Biol Interact; 1972 May; 4(6):409-19. PubMed ID: 5030586
    [No Abstract]   [Full Text] [Related]  

  • 33. Biomonitoring of aromatic amines. III: Hemoglobin binding of benzidine and some benzidine congeners.
    Birner G; Albrecht W; Neumann HG
    Arch Toxicol; 1990; 64(2):97-102. PubMed ID: 2350241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring exposure to 4,4'-methylenedianiline by the gas chromatography-mass spectrometry determination of adducts to hemoglobin.
    Bailey E; Brooks AG; Bird I; Farmer PB; Street B
    Anal Biochem; 1990 Nov; 190(2):175-81. PubMed ID: 2291463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrolyzable hemoglobin adducts of polyfunctional monocyclic N-substituted arenes as dosimeters of exposure and markers of metabolism.
    Zwirner-Baier I; Kordowich FJ; Neumann HG
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):43-5. PubMed ID: 7889857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.
    Lindeke B; Paulsen-Sörman U; Hallström G; Khuthier AH; Cho AK; Kammerer RC
    Drug Metab Dispos; 1982; 10(6):700-5. PubMed ID: 6130927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and decomposition of an ester derivative of the procarcinogen and promutagen, PhIP, 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine: unusual nitrenium ion chemistry.
    Nguyen TM; Novak M
    J Org Chem; 2007 Jun; 72(13):4698-706. PubMed ID: 17542636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic activation of aromatic amines by human pancreas.
    Anderson KE; Hammons GJ; Kadlubar FF; Potter JD; Kaderlik KR; Ilett KF; Minchin RF; Teitel CH; Chou HC; Martin MV; Guengerich FP; Barone GW; Lang NP; Peterson LA
    Carcinogenesis; 1997 May; 18(5):1085-92. PubMed ID: 9163700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships for mono alkylated or halogenated phenols.
    Schultz TW; Cajina-Quezada M
    Toxicol Lett; 1987 Jul; 37(2):121-30. PubMed ID: 3111016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.